Search
Support us
  • RESEARCH
  • PUBLICATIONS
  • AUTHOR CORRECTION: INTERLEUKIN 17 SIGNALING SUPPORTS CLINICAL BENEFIT OF DUAL CTLA-4 AND PD-1 CHECKPOINT INHIBITION IN MELANOMA.

Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.

  • Show more authors
    + 27
  • Renáta Váraljai
  • Lisa Zimmer
  • Yahya Al-Matary
  • Paulien Kaptein
  • Lea J Albrecht
  • Batool Shannan
  • Jan C Brase
  • Daniel Gusenleitner
  • Teresa Amaral
  • Nina Wyss
  • Jochen Utikal
  • Lukas Flatz
  • Florian Rambow
  • Hans Christian Reinhardt
  • Jenny Dick
  • Daniel R Engel
  • Susanne Horn
  • Selma Ugurel
  • Wiebke Sondermann
  • Elisabeth Livingstone
  • Antje Sucker
  • Annette Paschen
  • Fang Zhao
  • Jan M Placke
  • Jasmin M Klose
  • Wolfgang P Fendler
  • Daniela S Thommen
  • Iris Helfrich
  • Dirk Schadendorf
  • Alexander Roesch

More about this publication

Nature cancer
  • Volume 4
  • Issue nr. 9
  • Pages 1395
  • Publication date 01-09-2023
Full text links

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.